U.S. market Closed. Opens in 4 minutes

CRL | Charles River Laboratories International, Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for CRL we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is poor, Growth is exceptionally good and Health is weak.

Valuation (69%)

Company Industry
P/E Ratio (TTM) 21.74 34.95
PEG Ratio (TTM) -13.45 -7.77
P/S Ratio (TTM) 2.31 6.47
P/B Ratio (TTM) 2.52 1.18
P/FCF Ratio (TTM) 19.31 23.77
Price to 5YR AVG Earnings Ratio 23.27 126.73
Price to 5YR AVG FCF Ratio 22.34 94.49

Profitability (50%)

Company Industry
ROA (TTM) 5.43% 5.11%
ROE (TTM) 12.11% -0.10%
Net Profit Margin (TTM) 10.59% 10.46%
ROIC 5YR AVG 10.63% 11.75%

Growth (85%)

4QTR AVG 3YR AVG 5YR AVG
EPS 16.70% 19.14% 15.49%
Revenue -0.79% 16.10% 12.89%
Net Income 18.45% 21.07% 17.04%
Cash Flow 13.51% 17.61% 8.93%

Health (47%)

Company Industry
Current Ratio (TTM) 1.58 1.73
Quick Ratio (TTM) 1.21 1.29
D/E Ratio (TTM) 0.64 -1.07
Interest Coverage (TTM) 4.42 -27.40
Piotroski F-Score 6 5
Altman Z-Score 2.58 12.33
LTL to 5YR AVG FCF 7.29 3.30
Shares Outstanding Growth 5YR AVG 1.33% 1.22%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙